Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 9;15(8):5408-22.
doi: 10.3390/molecules15085408.

Using topological indices to predict anti-Alzheimer and anti-parasitic GSK-3 inhibitors by multi-target QSAR in silico screening

Affiliations

Using topological indices to predict anti-Alzheimer and anti-parasitic GSK-3 inhibitors by multi-target QSAR in silico screening

Isela García et al. Molecules. .

Abstract

Plasmodium falciparum, Leishmania, Trypanosomes, are the causers of diseases such as malaria, leishmaniasis and African trypanosomiasis that nowadays are the most serious parasitic health problems worldwide. The great number of deaths and the few drugs available against these parasites, make necessary the search for new drugs. Some of these antiparasitic drugs also are GSK-3 inhibitors. GSKI-3 are candidates to develop drugs for the treatment of Alzheimer's disease. In this work topological descriptors for a large series of 3,370 active/non-active compounds were initially calculated with the ModesLab software. Linear Discriminant Analysis was used to fit the classification function and it predicts heterogeneous series of compounds like paullones, indirubins, meridians, etc. This study thus provided a general evaluation of these types of molecules.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Some compounds studied in this article.
Figure 2
Figure 2
ModesLab software.

Similar articles

Cited by

References

    1. Olson R.E. Secretase inhibitors as therapeutics for Alzheimer’s disease. Annu. Rep. Med. Chem. 2000;35:31–40. doi: 10.1016/S0065-7743(00)35005-9. - DOI
    1. Brion J.P., Anderton B.H., Authelet M., Dayanandan R., Leroy K., Lovestone S., Ocatve J.N., Pradier L., Touchet N., Tremp G. Neurofibrillary Tangles and Tau Phosphorilation. Biochem. Soc. Symp. 2001;67:81–88. - PubMed
    1. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–259. doi: 10.1007/BF00308809. - DOI - PubMed
    1. Iqbal K., Alonso A., Chen S., Chohan M.O., El-Akkad E., Gong C., Khatoon S., Li B., Liu F., Rahman A., TAnimukai H., Grundke-Iqbal I. Tau pathology in Alzheimer disease and other tauopathies. BBA-Mol. Basis Dis. 2005;1739:198–210. doi: 10.1016/j.bbadis.2004.09.008. - DOI - PubMed
    1. Cohen P., Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2001;2:769–776. doi: 10.1038/35096075. - DOI - PubMed

Publication types

MeSH terms

Substances